Transaction summary
- Target
- Ci:z Holdings Co., Ltd.
- Acquirer
- Johnson & Johnson
- Seller
- -
- Announced
- 2018-10-23
- Geography
- Japan
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-06-18
- Latest update
- 2026-10-21
Value and multiples
100% enterprise value
USD 2.1B
100% enterprise value | USD
Basis: Public source
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
EV / revenue
4.5x
Period not stated
Basis: FundComb estimate
EV / EBITDA
22x
EBITDA basis not stated
Basis: FundComb estimate
Basis
- Fierce Pharma reported a USD 2.1bn deal on 23 October 2018, and Johnson & Johnson completed the acquisition on 17 January 2019. Revenue of USD 467m and EBITDA of USD 95m come from FundComb’s comps spreadsheet and are not confirmed by a public source. With USD 2.1bn they give estimated multiples of 4.5x revenue and 22.0x EBITDA; the period is not stated.
Source summary
Johnson & Johnson Completes Acquisition of Ci:z Holdings Co., Ltd. - PR Newswire
ConfirmedContinue your research
Related transaction comps
Beauty
Dr. Barbara Sturm acquired by Puig
2024-01-01 · Estimated
View transaction → BeautyGo-To Skincare acquired by Zoë Foster Blake
2023-12-15 · Confirmed
View transaction → BeautySol de Janeiro acquired by L'Occitane
2021-11-15 · Estimated
View transaction → BeautyObagi acquired by Waldencast
2021-11-15 · Confirmed
View transaction →